Related Experiment Video
Updated: Dec 4, 2025

Investigating Intestinal Barrier Breakdown in Living Organoids
Published on: March 26, 2020
Contributions of HO-1-Dependent MAPK to Regulating Intestinal Barrier Disruption
Zhenling Zhang1, Qiuping Zhang2, Fang Li3
1Department of Gastroenterology, the First Affiliated Hospital of Dalian Medical University, Dalian116011, China.
Abstract:
The mitogen-activated protein kinase (MAPK) pathway controls intestinal epithelial barrier permeability by regulating tight junctions (TJs) and epithelial cells damage. Heme oxygenase-1 (HO-1) and carbon monoxide (CO) protect the intestinal epithelial barrier function, but the molecular mechanism is not yet clarified. MAPK activation and barrier permeability were studied using monolayers of Caco-2 cells treated with tissue necrosis factor α (TNF-α) transfected with FUGW-HO-1 or pLKO.1-sh-HO-1 plasmid. Intestinal mucosal barrier permeability and MAPK activation were also investigated using carbon tetrachloride (CCl4) administration with CoPP (a HO-1 inducer), ZnPP (a HO-1 inhibitor), CO releasing molecule 2 (CORM-2), or inactived-CORM-2-treated wild-type mice and mice with HO-1 deficiency in intestinal epithelial cells. TNF-α increased epithelial TJ disruption and cleaved caspase-3 expression, induced ERK, p38, and JNK phosphorylation. In addition, HO-1 blocked TNF-α-induced increase in epithelial TJs disruption, cleaved caspase-3 expression, as well as ERK, p38, and JNK phosphorylation in an HO-1-dependent manner. CoPP and CORM-2 directly ameliorated intestinal mucosal injury, attenuated TJ disruption and cleaved caspase-3 expression, and inhibited epithelial ERK, p38, and JNK phosphorylation after chronic CCl4 injection. Conversely, ZnPP completely reversed these effects. Furthermore, mice with intestinal epithelial HO-1 deficient exhibited a robust increase in mucosal TJs disruption, cleaved caspase-3 expression, and MAPKs activation as compared to the control group mice. These data demonstrated that HO-1-dependent MAPK signaling inhibition preserves the intestinal mucosal barrier integrity by abrogating TJ dysregulation and epithelial cell damage. The differential targeting of gut HO-1-MAPK axis leads to improved intestinal disease therapy.
Insights
Heme oxygenase-1 (HO-1) and carbon monoxide (CO) protect the intestinal barrier by inhibiting the MAPK pathway, reducing cell damage and tight junction disruption. Targeting this HO-1-MAPK axis may improve intestinal disease therapies.
Area of Science:
- Gastroenterology
- Molecular Biology
- Cell Biology
Background:
- The mitogen-activated protein kinase (MAPK) pathway regulates intestinal epithelial barrier function, influencing tight junctions (TJs) and cell damage.
- Heme oxygenase-1 (HO-1) and its product carbon monoxide (CO) are known to protect the intestinal barrier, but the underlying molecular mechanisms require further elucidation.
Purpose of the Study:
- To investigate the molecular mechanism by which HO-1 and CO protect the intestinal epithelial barrier function.
- To determine the role of the MAPK pathway in HO-1-mediated protection of the intestinal barrier.
Main Methods:
- Caco-2 cell monolayers were treated with TNF-α and transfected with HO-1 or sh-HO-1 plasmids to study MAPK activation and barrier permeability.
- Wild-type and HO-1-deficient mice were treated with carbon tetrachloride (CCl4) and administered HO-1 inducers (CoPP) or inhibitors (ZnPP), or CO-releasing molecules (CORM-2) to assess mucosal barrier integrity and MAPK activation.
Main Results:
- TNF-α induced TJ disruption, cleaved caspase-3 expression, and phosphorylation of ERK, p38, and JNK.
- HO-1 expression inhibited TNF-α-induced TJ disruption, cleaved caspase-3, and MAPK phosphorylation in an HO-1-dependent manner.
- CoPP and CORM-2 ameliorated CCl4-induced intestinal injury, TJ disruption, and MAPK activation, while ZnPP reversed these effects. HO-1 deficient mice showed increased barrier disruption and MAPK activation.
Conclusions:
- HO-1-dependent inhibition of MAPK signaling preserves intestinal mucosal barrier integrity by preventing TJ dysregulation and epithelial cell damage.
- Targeting the gut HO-1-MAPK axis presents a promising therapeutic strategy for intestinal diseases.
More Related Videos
09:24Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
10:22In Vitro and In Vivo Approaches to Determine Intestinal Epithelial Cell Permeability
Published on: October 19, 2018
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Renewal of Intestinal Stem Cells
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Physiology of Enteric Nervous System and Gut Health
MAPK Signaling Cascades